Cargando…
Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
Gastrointestinal inflammation is a hallmark of highly prevalent disorders, including cancer treatment–induced mucositis and ulcerative colitis. These disorders cause debilitating symptoms, have a significant impact on quality of life, and are poorly managed. The activation of toll-like receptor 4 (T...
Autores principales: | Tam, Janine S. Y., Coller, Janet K., Hughes, Patrick A., Prestidge, Clive A., Bowen, Joanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934812/ https://www.ncbi.nlm.nih.gov/pubmed/33666891 http://dx.doi.org/10.1007/s12664-020-01114-y |
Ejemplares similares
-
Investigation of TLR4 Antagonists for Prevention of Intestinal Inflammation
por: Tam, Janine S. Y., et al.
Publicado: (2022) -
Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity
por: Tam, Janine S. Y., et al.
Publicado: (2022) -
Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis
por: Crame, Elise E., et al.
Publicado: (2022) -
Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
por: Leon, Carlos G., et al.
Publicado: (2008) -
Toll-Like Receptor 4 (TLR4) and Typhoid Fever in Vietnam
por: Hue, Nguyen Thi, et al.
Publicado: (2009)